Türkiye Psikiyatri Derneği YILLIK TOPLANTISI VE 2.ULUSLARARASI 26. ULUSAL KLİNİK EĞİTİM SEMPOZYUMU, Mersin, Turkey, 9 - 12 May 2024, pp.27
This presentation aimed to review emerging or over-the-horizon therapies for treating BD. Published in 2023 and the first period of 2024, systematic reviews and meta-analyses related to BD treatments, the efficacy of new antipsychotic agents such as lumateperone, olanzapine/samidorphan, and aripiprazole 2-month long-acting injectable in BD treatments, duration of use of antidepressant add-on treatments in bipolar depression, cannabidiol add-on strategies in bipolar depression, the effect of age on the anti-suicidal efficacy of lithium, the effectiveness of esketamine in treatment-resistant bipolar depression, the effectiveness of psilocybin-assisted psychotherapy in treatment-resistant bipolar depression, the role of anti-inflammatory agents in the adjunctive treatment of bipolar mania and bipolar depression and many other issues related to the treatment of BD will be discussed.